IDYA - IDEAYA Biosciences, Inc. - Rantaian Opsyen

IDEAYA Biosciences, Inc.
US ˙ NasdaqGS ˙ US45166A1025

Tamat tempoh
Calls untuk tarikh pasaran September 05, 2025
Kontrak Strike Bida Tawar Terakhir Volum OI IV Delta Gamma Theta Vega Rho
IDYA20250919C00012500 12.50 12.90 17.00 0.00 0 0 296.46% 0.95 0.01 -0.06 0.01 0.00
IDYA20250919C00015000 15.00 10.10 14.50 0.00 0 0 250.57% 0.92 0.01 -0.07 0.01 0.00
IDYA20250919C00017500 17.50 8.70 12.00 0.00 0 0 228.43% 0.88 0.02 -0.08 0.01 0.00
IDYA20250919C00020000 20.00 6.30 9.70 6.90 12 30 123.41% 0.91 0.03 -0.04 0.01 0.00
IDYA20250919C00022500 22.50 4.40 6.70 5.00 2 10 80.19% 0.89 0.05 -0.03 0.01 0.00
IDYA20250919C00025000 25.00 3.00 4.10 3.70 75 1,608 98.78% 0.68 0.07 -0.07 0.02 0.00
IDYA20250919C00030000 30.00 1.05 1.75 1.60 54 492 114.47% 0.36 0.06 -0.08 0.02 0.00
Puts untuk tarikh pasaran September 05, 2025
Kontrak Strike Bida Tawar Terakhir Volum OI IV Delta Gamma Theta Vega Rho
IDYA20250919P00012500 12.50 0.00 3.80 0.00 0 0 481.51% -0.10 0.01 -0.16 0.01 -0.00
IDYA20250919P00015000 15.00 0.00 0.10 0.00 0 10 149.94% -0.02 0.01 -0.01 0.00 -0.00
IDYA20250919P00017500 17.50 0.00 3.80 0.00 0 0 317.67% -0.16 0.01 -0.14 0.01 -0.00
IDYA20250919P00020000 20.00 0.00 1.90 0.00 0 2 183.98% -0.16 0.02 -0.08 0.01 -0.00
IDYA20250919P00022500 22.50 0.00 0.90 0.00 0 416 92.52% -0.14 0.05 -0.04 0.01 -0.00
IDYA20250919P00025000 25.00 0.95 1.85 1.50 8 5 103.94% -0.32 0.06 -0.07 0.02 -0.00
IDYA20250919P00030000 30.00 2.60 6.50 0.00 0 1 124.49% -0.62 0.06 -0.09 0.02 -0.01
Other Listings
DE:30J €22.40
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista